ADMA compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

ADMAAdma Biologics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

ADMAAdma Biologics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ADMA

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±15.2%▲+26.05%×1.72

Q2 FY26±11.7%▲+8.64%×0.74

May 7 '26±14.1%▼−15.97%×1.13

Q1 FY26±10.9%▼−3.19%×0.29

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

= impliedADMA realized, solidAMGN realized, hatchedOne scale, both sides: full bar = 27%× = |realized| ÷ impliedSource: market data

Q1 FY26

±3.9%

▼−4.75%

×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

ADMAAdma Biologics, Inc.

13.11▼−0.78%

Mkt cap$2.9BRevenue$141MQ3 FY26Revenue$510MFY25

AMGNAmgen Inc

460.33▲+0.01%

Regular sessionNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Regular sessionNov 6 '26

ADMAAdma Biologics, Inc.

AMGNAmgen Inc

13.11▼−0.78%

Price

460.33▲+0.01%

$2.9B

Mkt cap

$249.0B

Q3 FY26$141M

Revenue

$10.4BQ3 FY26

FY25$510M

Revenue

$36.8BFY25

ADMA13.11▼−0.78%vsAMGN460.33▲+0.01%Regular sessionNov 6 '26